188 related articles for article (PubMed ID: 29886411)
1. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.
Daly AT; Deshmukh AA; Vidrine DJ; Prokhorov AV; Frank SG; Tahay PD; Houchen ME; Cantor SB
Tob Control; 2019 Jan; 28(1):88-94. PubMed ID: 29886411
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION.
Vidrine DJ; Fletcher FE; Danysh HE; Marani S; Vidrine JI; Cantor SB; Prokhorov AV
BMC Public Health; 2012 Aug; 12():696. PubMed ID: 22920991
[TBL] [Abstract][Full Text] [Related]
3. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation.
Richter KP; Shireman TI; Ellerbeck EF; Cupertino AP; Catley D; Cox LS; Preacher KJ; Spaulding R; Mussulman LM; Nazir N; Hunt JJ; Lambart L
J Med Internet Res; 2015 May; 17(5):e113. PubMed ID: 25956257
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Enhanced vs Standard Varenicline Treatment for Tobacco Cessation.
Mundt MP; Stein JH; Fiore MC; Baker TB
JAMA Netw Open; 2024 Apr; 7(4):e248727. PubMed ID: 38683609
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Tosanguan J; Chaiyakunapruk N
Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
10. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
14. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.
Mundt MP; Baker TB; Fraser DL; Smith SS; Piper ME; Fiore MC
Value Health; 2019 Feb; 22(2):177-184. PubMed ID: 30711062
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Mobile Phone-Delivered Smoking Cessation Interventions for Socioeconomically Disadvantaged Individuals: A Randomized Clinical Trial.
Vidrine DJ; Frank-Pearce SG; Vidrine JI; Tahay PD; Marani SK; Chen S; Yuan Y; Cantor SB; Prokhorov AV
JAMA Intern Med; 2019 Feb; 179(2):167-174. PubMed ID: 30556832
[TBL] [Abstract][Full Text] [Related]
16. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of a Health System-Based Smoking Cessation Program.
Levy DE; Klinger EV; Linder JA; Fleegler EW; Rigotti NA; Park ER; Haas JS
Nicotine Tob Res; 2017 Nov; 19(12):1508-1515. PubMed ID: 27639095
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.
Hoogendoorn M; Feenstra TL; Hoogenveen RT; Rutten-van Mölken MP
Thorax; 2010 Aug; 65(8):711-8. PubMed ID: 20685746
[TBL] [Abstract][Full Text] [Related]
20. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Bolin K; Lindgren B; Willers S
Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
